June 16, 2020

Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach to integrated solutions for clinical and commercial advanced therapy manufacturers. As a key part of this new network, we’ve also announced a collaboration with Mavens to support cell and gene therapy developers with a fully integrated solution.

The Vineti Alliance Network will make it easy for pharmaceutical and biotechnology companies to identify and source a wide range of advanced therapy supply chain vendors who work with Vineti’s leading cloud PTM platform. And as development of advanced therapies continues, even amid COVID-19, speed and simplicity matter more than ever.

Cell and gene therapies are inherently complex, and as I wrote in a STAT News op-ed in December, require their ecosystems and enabling technologies to work together in unprecedented ways to deliver patient treatments. Without built-for-purpose collaboration, our field will simply not scale quickly enough.  The Vineti Alliance Network is a simpler, faster “marketplace” way to make that all-important collaboration happen up front. 

These types of pre-built integration partnerships are common in other areas of enterprise software (think the Salesforce AppExchange, or Veeva on the Apple App Store). It’s time to support advanced therapies with similar integrated infrastructure. The Vineti PTM platform remains independent and agnostic with respect to integrations, but we also seek to drive a set of process and service standards to industrialize advanced therapies. Great science can’t reach patients on its own. Our Alliance Network is a key next step.

We’re also very excited to welcome Mavens as a key member of the new network. Mavens is a leading provider of consulting and software for the life sciences and patient service solutions for cell and gene therapy. Mavens’ Cell & Gene Navigator, built on Salesforce Health Cloud, supports cutting-edge concierge services that power patient services hubs for specialty pharma and rare disease, and will seamlessly integrate with Vineti’s personalized therapy management solution. 

You can learn more details in today’s announcement. And if you’d like to learn more, please contact us. We’re very pleased to already be working with 14 leading collaborators in our Alliance Network, and are looking forward to welcoming many more in the months ahead. Thank you! 

Amy DuRoss is the CEO and Co-founder of Vineti. If you’d like to learn more about how Vineti’s Personalized Therapy Management (PTM) is helping to standardize and industrialize workflows for personalized therapies, please contact us.

PIM logo